NDAORALCAPSULE
Approved
Jul 1958
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 11h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SYNALGOS-DC is a fixed-dose combination oral capsule containing aspirin, caffeine, and dihydrocodeine bitartrate approved in 1958. It is indicated for moderate pain relief where the combination of analgesic and mild opioid action provides enhanced efficacy. The product works via aspirin's anti-inflammatory and analgesic properties, caffeine's mild stimulant and potentiation effects, and dihydrocodeine's opioid-mediated pain relief.
LOE Approaching
With LOE approaching and no current patent protection data, this product is in transition and likely operating with a small specialized team focused on managed decline or niche positioning.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
With zero linked job openings and LOE approaching, career opportunities on SYNALGOS-DC are limited and focused on portfolio management and stakeholder relations rather than growth. Professionals joining this product should expect a maintenance-focused role with emphasis on compliance, managed decline, and transition planning.
Brand ManagerProduct Manager
Worked on SYNALGOS-DC at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.